Sign in
4

Changes in Ownership

Oric Pharmaceuticals, Inc. Filed Acc 0001608936-25-000006

PRESIDENT AND CEO sold 125,000 shares at $10.80 ($1,349,938)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Chacko Jacob PRESIDENT AND CEO 2025-09-22 Sale 10b5-1 −125,000 $10.80 $1,349,938 656,419 D
Open-market sales · 125,000 sh · avg $10.80 · $1,349,938
Loading xslF345X05/form4-09242025_080916.xml…